Clinical Trials Browser

Phase 2 × belinostat × Plasma cell × Clear all

NCT00131261 2015-07-08

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms

NCT00431340 2015-07-08

A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma, Bone Marrow Neoplasms, Neoplasms, Plasma Cell